Published in Cancer Weekly, June 5th, 2006
"The objective of this study was to determine the accuracy, reproducibility, and clinical value of MR-VAB in a prospective, multicenter study. In 5 European centers, MR-VAB was performed or attempted on 538 suspicious lesions that were visible or could targeted only by MR imaging (MRI)," scientists in Germany reported.
"Verification of malignant or borderline lesions included reexcision of the biopsy cavity,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.